Skip to main content

Table 1 Alu115 of plasma DNA in subgroups of gastric cancer patients

From: Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA

Variable

patients

Alu115

p

No.

%

Sex

 male

46

63.01

783.75 (521.35–1223.63)

0.045

 female

27

36.99

1484.50 (414.70–2295.50)

 

AJCC primary tumor

 Tis-T1

12

16.44

818.4 (478.45–1732.75)

0.724

 T2

12

16.44

966.9 (432–1496.25)

 

 T3

5

6.85

1153.5 (394.00–1238.75)

 

 T4

44

60.27

1146.5 (676.7–1878.5)

 

AJCC regional lymph nodes

 N0

31

42.47

1079.5 (408.2–1544)

0.362

 N1

8

10.96

1281 (1106–4104.25)

 

 N2

14

19.18

1390.5 (606.65–1949.5)

 

 N3

20

27.40

925.4 (579.55–2087)

 

AJCC distant metastasis

 M0

63

86.30

1079.5 (552.95–1670)

0.275

 M1

10

13.70

1666.5 (754.25–2479.5)

 

AJCC stage

0-I

19

26.03

1027.65 (408.2–1935)

0.676

II

11

15.07

1484.5 (400.7–1670)

 

III

33

45.20

1065.5 (676.7–1572.5)

 

IV

10

13.70

1666.5 (754.25–2479.5)

 

Histopathologic grade

 middle -high

19

26.04

906.150 (359.50–1213.00)

0.811

 low

41

56.16

786.250 (411.45–1586.25)

 

 unknow

13

17.81

  

Lymphovascular invasion

 positive

18

24.66

1190.00 (551.04–1971.88)

0.653

 negative

12

16.44

1146.50 (400.70–1389.50)

 

 unknow

43

58.90